This paper adds to existing evidence about the cost of increasing regulation in foregone economic growth and highlights the issue for policymakers. The effects of growing regulation on the pace of ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

NYU Langone has built an LLM research companion and medical advisor, and is pioneering what it calls AI-driven “precision ...

Tesla's FSD advantage could be threatened by BYD's new God's Eye autonomous driving capability. Click here to find out why I ...

A security vulnerability in the Indian Post Office portal has exposed sensitive Know Your Customer (KYC) data of thousands of users through an Insecure Direct Object Reference (IDOR) attack vector.

USDA Animal and Plant Health Inspection Service (APHIS) announced on January 23, 2025, that it is reinstating its legacy ...

Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...

Strong Non-Human Identity Verification. Zero trust begins with verifying identity, and PKI provides an unmatched level of ...

Trump has always been a wrecking ball, but now that he’s pummeling Big Tech’s perceived enemies, he’s become a hero to a ...

The UK government’s AI Opportunities Action Plan promises billions in investment to position Britain as a leader in ...

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)[1] and OXB,[2] today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an osteoarthritis treatment in human trials may have potential for treating RA.